Previous works indicate that CDKN1C protein expression scored by immunohistochemistry (but not mRNA expression) prior to treatment help anticipate the clinical response of patients with MDS to conventional chemotherapy37. Here, CDKN1C is linked to myelodysplastic syndrome.